Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
BlackRock, Inc.'s stake in Zentalis Pharmaceuticals, Inc. fell to 2.20% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc.'s stake in Zentalis Pharmaceuticals, Inc. fell to 2.20%, 1,613,323 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 2.20%
- Shares
- 1,613,323
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 2.20% | 1,613,323 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- BlackRock, Inc.
- Zentalis Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Form 4 · Johnson David Michael · Jun 18, 2026